Clinical Trial Update: ProQuad Dose Selection Study (V221-011)(COMPLETED) [Phase 2]

View source ↗

Summary

A Phase 2 dose-selection study of ProQuad evaluated different dosing regimens to determine the optimal dose for protection against measles, mumps, rubella, and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Measles
• Mumps
• Rubella
• Varicella

Drugs mentioned

• ProQuad (Measles, Mumps, Rubella and Varicella live attenuated vaccine)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Measles, Mumps | Phase 2 | Status: COMPLETED | Results posted: 2010-02-15